Sara Norcross

Vice President and General Manager, Novo Nordisk

Sara Norcross is Vice President and General Manager of Novo Nordisk.

Novo Nordisk South Africa is the local arm of the Danish diabetes and obesity drugmaker and sells Ozempic and Wegovy. Under Norcross it launched Wegovy for weight management in August 2025 and an authorised semaglutide copy in 2026.

In the job

  1. Novo Nordisk launched Wegovy for weight management in South Africa, where it already sold Ozempic for diabetes. Source

  2. Novo Nordisk South Africa launched an authorised semaglutide copy at a lower price, made on the same production lines as the original. Source

  3. Novo Nordisk South Africa said it had identified and reported suspected unlawful online sales of weight-loss drugs. Source

Sources

  1. bizcommunity.com
  2. pressportal.co.za
  3. bizcommunity.com
  4. businesstech.co.za
  5. medicaldialogues.in

Facts last checked 3 November 2026. Spotted something out of date? Tell us.

More profiles

All profiles
Pharmaceuticals Andy Hall Chief Executive Officer, Adcock Ingram Since 2015
Pharmaceuticals Joanna Johnston Country President, Novartis South Africa
Pharmaceuticals Morena Makhoana Chief Executive Officer, Biovac
Pharmaceuticals Paul Miller Chief Executive Officer, Cipla Africa, Cipla South Africa